{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:32:49Z","timestamp":1765546369244},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1097\/md.0000000000012206","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T07:05:42Z","timestamp":1538204742000},"page":"e12206","source":"Crossref","is-referenced-by-count":6,"title":["Effects of prophylactic oral ibuprofen on the closure rate of patent ductus arteriosus in premature infants"],"prefix":"10.1097","volume":"97","author":[{"given":"Yanjie","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaju","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-28-20210226","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0735-1097(02)01886-7","article-title":"The incidence of congenital heart disease","volume":"39","author":"Hoffman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R2-28-20210226","doi-asserted-by":"crossref","first-page":"F505","DOI":"10.1136\/archdischild-2013-303816","article-title":"Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3","volume":"98","author":"Sellmer","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R3-28-20210226","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJM200009073431009","article-title":"Ibuprofen and patent ductus arteriosus","volume":"343","author":"Clyman","year":"2000","journal-title":"N Engl J Med"},{"key":"R4-28-20210226","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.semperi.2013.01.006","article-title":"The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia","volume":"37","author":"Clyman","year":"2013","journal-title":"Semin Perinatol"},{"key":"R5-28-20210226","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1542\/peds.2009-3506","article-title":"Patent ductus arteriosus of the preterm infant","volume":"125","author":"Hamrick","year":"2010","journal-title":"Pediatrics"},{"key":"R6-28-20210226","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJM197609022951004","article-title":"Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis","volume":"295","author":"Heymann","year":"1976","journal-title":"N Engl J Med"},{"key":"R7-28-20210226","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJM197609022951003","article-title":"Pharmacologic closure of patent ductus arteriosus in the premature infant","volume":"295","author":"Friedman","year":"1976","journal-title":"N Engl J Med"},{"key":"R8-28-20210226","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/08998280.2007.11928244","article-title":"Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus","volume":"20","author":"Poon","year":"2007","journal-title":"Proc (Bayl Univ Med Cent"},{"key":"R9-28-20210226","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/clpt.2011.284","article-title":"High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study","volume":"91","author":"Dani","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"R10-28-20210226","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2125.2008.03118.x","article-title":"An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study","volume":"65","author":"Hirt","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R11-28-20210226","doi-asserted-by":"crossref","first-page":"e1024","DOI":"10.1542\/peds.2013-3431","article-title":"PDA ligation and health outcomes: a meta-analysis","volume":"133","author":"Weisz","year":"2014","journal-title":"Pediatrics"},{"key":"R12-28-20210226","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1542\/peds.2005-0293","article-title":"Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation","volume":"116","author":"Sperandio","year":"2005","journal-title":"Pediatrics"},{"key":"R13-28-20210226","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamapediatrics.2015.0987","article-title":"Diagnosis, evaluation, and management of patent ductus arteriosus in preterm neonates","volume":"169","author":"Jain","year":"2015","journal-title":"JAMA Pediatr"},{"key":"R14-28-20210226","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/S0140-6736(04)17476-X","article-title":"Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial","volume":"364","author":"Gournay","year":"2004","journal-title":"Lancet"},{"key":"R15-28-20210226","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(04)17477-1","article-title":"Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"364","author":"Van Overmeire","year":"2004","journal-title":"Lancet"},{"key":"R17-28-20210226","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000335332","article-title":"Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis","volume":"102","author":"Neumann","year":"2012","journal-title":"Neonatology"},{"key":"R18-28-20210226","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.earlhumdev.2015.08.003","article-title":"Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus","volume":"91","author":"Gulack","year":"2015","journal-title":"Early Hum Dev"},{"key":"R20-28-20210226","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1055\/s-0035-1551671","article-title":"The effect of oral high-dose ibuprofen on patent ductus arteriosus closure in preterm infants","volume":"32","author":"Pourarian","year":"2015","journal-title":"Am J Perinatol"},{"key":"R21-28-20210226","doi-asserted-by":"crossref","first-page":"e2005","DOI":"10.5812\/ijp.2005","article-title":"High-dose oral ibuprofen in treatment of patent ductus arteriosus in full-term neonates","volume":"25","author":"Pourarian","year":"2015","journal-title":"Iran J Pediatr"},{"key":"R22-28-20210226","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1651-2227.2000.tb00767.x","article-title":"Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants","volume":"89","author":"Dani","year":"2000","journal-title":"Acta Paediatr"},{"key":"R23-28-20210226","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1651-2227.2010.02027.x","article-title":"Echocardiographic prediction of patent ductus arteriosus in need of therapeutic intervention","volume":"100","author":"Harling","year":"2011","journal-title":"Acta Paediatr"},{"key":"R24-28-20210226","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/apa.12103","article-title":"Early colour Doppler duct diameter and symptomatic patent ductus arteriosus in a cyclo-oxygenase inhibitor naive population","volume":"102","author":"Heuchan","year":"2013","journal-title":"Acta Paediatr (Oslo, Norway: 1992"},{"key":"R25-28-20210226","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00431-014-2350-2","article-title":"Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life","volume":"173","author":"Letshwiti","year":"2014","journal-title":"Eur J Pediatr"},{"key":"R26-28-20210226","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/apa.12892","article-title":"B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants","volume":"104","author":"K\u00f6nig","year":"2015","journal-title":"Acta Paediatr"},{"key":"R27-28-20210226","first-page":"67","article-title":"Aminoterminal B-type natriuretic peptide (NT-proBNP) in the therapy of patent ductus arteriosus","volume":"62","author":"Bagnoli","year":"2010","journal-title":"Minerva Pediatr"},{"key":"R28-28-20210226","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/jp.2008.185","article-title":"N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants","volume":"29","author":"Nuntnarumit","year":"2009","journal-title":"J Perinatol"},{"key":"R29-28-20210226","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s003800200019","article-title":"The role of endothelin in oxygen-induced contraction of the ductus arteriosus in rabbit and rat fetuses","volume":"16","author":"Shen","year":"2002","journal-title":"Heart Vessels"},{"key":"R30-28-20210226","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40272-013-0031-7","article-title":"Clinical pharmacology of indomethacin in preterm infants: implications in patent ductus arteriosus closure","volume":"15","author":"Pacifici","year":"2013","journal-title":"Pediatr Drugs"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000012206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:25:59Z","timestamp":1620962759000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201809140-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":28,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000012206","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}